Know more

About cookies

What is a "cookie"?

A "cookie" is a piece of information, usually small and identified by a name, which may be sent to your browser by a website you are visiting. Your web browser will store it for a period of time, and send it back to the web server each time you log on again.

Different types of cookies are placed on the sites:

  • Cookies strictly necessary for the proper functioning of the site
  • Cookies deposited by third party sites to improve the interactivity of the site, to collect statistics

Learn more about cookies and how they work

The different types of cookies used on this site

Cookies strictly necessary for the site to function

These cookies allow the main services of the site to function optimally. You can technically block them using your browser settings but your experience on the site may be degraded.

Furthermore, you have the possibility of opposing the use of audience measurement tracers strictly necessary for the functioning and current administration of the website in the cookie management window accessible via the link located in the footer of the site.

Technical cookies

Name of the cookie


Shelf life

CAS and PHP session cookies

Login credentials, session security



Saving your cookie consent choices

12 months

Audience measurement cookies (AT Internet)

Name of the cookie


Shelf life


Trace the visitor's route in order to establish visit statistics.

13 months


Store the anonymous ID of the visitor who starts the first time he visits the site

13 months


Identify the numbers (unique identifiers of a site) seen by the visitor and store the visitor's identifiers.

13 months

About the AT Internet audience measurement tool :

AT Internet's audience measurement tool Analytics is deployed on this site in order to obtain information on visitors' navigation and to improve its use.

The French data protection authority (CNIL) has granted an exemption to AT Internet's Web Analytics cookie. This tool is thus exempt from the collection of the Internet user's consent with regard to the deposit of analytics cookies. However, you can refuse the deposit of these cookies via the cookie management panel.

Good to know:

  • The data collected are not cross-checked with other processing operations
  • The deposited cookie is only used to produce anonymous statistics
  • The cookie does not allow the user's navigation on other sites to be tracked.

Third party cookies to improve the interactivity of the site

This site relies on certain services provided by third parties which allow :

  • to offer interactive content;
  • improve usability and facilitate the sharing of content on social networks;
  • view videos and animated presentations directly on our website;
  • protect form entries from robots;
  • monitor the performance of the site.

These third parties will collect and use your browsing data for their own purposes.

How to accept or reject cookies

When you start browsing an eZpublish site, the appearance of the "cookies" banner allows you to accept or refuse all the cookies we use. This banner will be displayed as long as you have not made a choice, even if you are browsing on another page of the site.

You can change your choices at any time by clicking on the "Cookie Management" link.

You can manage these cookies in your browser. Here are the procedures to follow: Firefox; Chrome; Explorer; Safari; Opera

For more information about the cookies we use, you can contact INRAE's Data Protection Officer by email at or by post at :


24, chemin de Borde Rouge -Auzeville - CS52627 31326 Castanet Tolosan cedex - France

Last update: May 2021

Menu Logo Principal

Home page

VESO Vikan

VESO Vikan
© Veso Vikan

Address: Vikan, N-7800 Namsos - Norway
Laboratory (ies) involved: VESO Vikan experimental facility

Research topics

Biomedical and pharmaceutical research in fish and other aquatic organisms involving infectious and emerging diseases

Access contact person

Anne Ramstad , Project Veterinary Manager

Activities and services

VESO Vikan is the world leading laboratory for disease trials in Atlantic salmon, Salmo salar L. and has its own hatchery for production of Atlantic salmon with known susceptibility to infectious diseases.

The facility is built to conduct clinical trials and other experiments with infectious diseases under stringent quarantine conditions, without discharge of infectious material to the aquatic environment. The facility can provide a full range of water qualities with respect to salinity, temperature and pH, and thus has the capacity to hold, maintain and manipulate a wide range of fresh water and marine species.

Several challenge models are available for Atlantic salmon, Cod, Sea Bass, Rainbow trout, etc. Our scientific staff has in depth experience in handling, management and care of fish in all stages operating according to OECD`s principles of Good Laboratory Practice. Living, working and conference buildings are located at the facility.

Description of the access to provide

  • VESO Vikan is the world leading laboratory for disease trials in Atlantic salmon. Tests involving a whole range of other aquatic species are also conducted.
  • VESO Vikan has a broad experience in bacterial and viral pathogens as well as parasites.
  • VESO Vikan comprises an experimental trials unit capable of conducting challenge trails with fish pathogens, a hatchery for supply of SPF experimental fish and a marine net pen unit for field trials.
  • The facility comprises 200 tanks of various sizes. The laboratory has experimental challenge models for several bacterial agents, viruses and parasites.
  • A well equipped dry laboratory is available.
  • We have a trained staff to give support to be able to conduct the experiments according to the project plan.

NUMBER of participants accepted:

8-10 projects, each project is estimated to approx 10 tank months (ca. 2500 euros)

Travel and subsistence costs

The project will cover visit to the facility at start of project, sampling and termination. Accommodation are free at the facility, food will be covered by Norwegian governmental rates and food must be prepared by the scientist at the accommodation. Travel costs are limited to approx 1000 euro per project.

Conditions of participant involvement

After the end of each project the candidate will:

  • Submit a short report
  • Fill a questionnaire available on-line at:
  • The participant is entitled to publish the results of its work at the infrastructure in the open literature.All publications resulting from the project should acknowledge this EC-support by mentioning : “The research leading to these results has received funding from the European Community‘s Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 228394”
  • Proprietary research (research where results are not generally available to the public or only made available under confidentiality arrangements) cannot be supported.
  • Travel and subsistence expenses linked to the access will be reimbursed upon approval of the report. Reimbursements will be done according to administrative rules of each hosting organisation.
  • For more information about transnational access conditions, see the ANNEX III to the Grant Agreement - Infrastructures

Infrastructure ethical rules

All project plans must be approved according to Norwegian legislation for the use of animals (fish) for research purposes. The project plans will be evaluated local or in the National Animal Research Authority (NARA).

Recent publications

  • T. Kanellos, I.D. Sylvester, F. D’Mello, C.R. Howard, A, Mackie, P.F. Dixon, K-C. Chang, A. Ramstad, P.J. Midtlyng, P.H. Russell (2006) DNA vaccination can protect Cyprinus Carpio against spring viraemia of carp virus. Vaccine 24, 4927-4933.
  • Storset A., Strand C., Wetten M., Kjøglum S., Ramstad A. (2007) Response to selection for resistance against infectious pancreatic necrosis in Atlantic salmon (Salmo salar L.). Aquaculture. 272S1 62-68
  • Ramstad A., A. B. Romstad, D.H. Knappskog and P.J. Midtlyng (2007) Field validation of experimental challenge models for IPN vaccines. Journal of Fish Diseases. 30, 723-731
  • Ramstad A. and P.J. Midtlyng (2008) Strong genetic influence on IPN vaccination -and challenge trials in Atlantic salmon (Salmo salar L.) Journal of Fish Diseases. 31, 567-578 13.

See also

Infrastructure website: